arrow_back Civic Audit
Share share

Condemning Biden Administration's Abortion Policies: Women's Health and Safety Concerns

This House Resolution condemns the Biden administration's policies regarding access to abortion medication, asserting they compromise the safety of women and girls. It highlights risks associated with a lack of medical oversight and the potential for misuse of the drugs against patients' will. The aim is to draw attention to potential health and safety threats for citizens.
Key points
The resolution condemns changes in the rules for dispensing mifepristone, an abortion medication, claiming they increase health risks for women.
It points to the removal of in-person doctor visit requirements and the allowance of mail-order dispensing, which could hinder the detection of complications like ectopic pregnancies.
It raises concerns that a lack of medical oversight might facilitate the misuse of the drug by third parties, for example, in cases of domestic abuse or human trafficking.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Print number: 118_HRES_1285
Sponsor: Rep. Moran, Nathaniel [R-TX-1]
Process start date: 2024-06-07
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Condemning the pro-abortion policies of the Biden administration.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HRES_1285.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2024-06-07.

What are the main provisions?

Key points include:

  • The resolution condemns changes in the rules for dispensing mifepristone, an abortion medication, claiming they increase health risks for women.
  • It points to the removal of in-person doctor visit requirements and the allowance of mail-order dispensing, which could hinder the detection of complications like ectopic pregnancies.
  • It raises concerns that a lack of medical oversight might facilitate the misuse of the drug by third parties, for example, in cases of domestic abuse or human trafficking.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Moran, Nathaniel [R-TX-1].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-24.

What is the impact of this bill?

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge.

CATEGORIES

Health Family Courts and Law